Cape Verde vs Jordan: Access to anti-retroviral drugs, male
Cape Verde
64.0%
in 2024
Jordan
64.0%
in 2024
Cape Verde rank
87th
Jordan rank
87th
Access to anti-retroviral drugs, male over time
- Cape Verde
- Jordan
How they compare
Cape Verde currently reports 64.0% against 64.0% in Jordan, a difference of 0.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Jordan ahead.
Cape Verde ranks 87th and Jordan ranks 87th of 141 countries.
Across the 3 decades both report, Cape Verde averaged higher in 2 and Jordan in 1.
Head to head by decade
| Decade | Cape Verde | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.0% | 20.6% | 10.6% | Jordan |
| 2010s | 43.6% | 42.9% | 0.7% | Cape Verde |
| 2020s | 61.8% | 53.8% | 8.0% | Cape Verde |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Cape Verde or Jordan?
- Cape Verde, at 64.0% against 64.0% in Jordan as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Cape Verde and Jordan?
- 0.0%, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and Jordan?
- 25 years are reported by both, from 2000 to 2024.
- How do Cape Verde and Jordan rank globally for access to anti-retroviral drugs, male?
- Cape Verde ranks 87th and Jordan ranks 87th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.